Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.32 |
| ▸ | HMGCR | P04035 | 3/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
| ▸ | KDM5A | P29375 | 2/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28041462 | 0.89 | — | — | |
| SCHEMBL29353408 | 0.88 | EPHX2 (0.34) | EPHX2 | |
| SCHEMBL29876681 | 0.88 | EPHX2 (0.34) | EPHX2 | |
| SCHEMBL30770170 | 0.85 | — | — | |
| SCHEMBL509830 | 0.84 | CA12 (0.33) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL5617071 | 0.83 | — | — | |
| SCHEMBL28018024 | 0.82 | MAPK1 (0.37) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL29445404 | 0.81 | ACHE (0.37) | — | |
| SCHEMBL28983307 | 0.81 | EPHX1 (0.33) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL31322084 | 0.80 | ALOX15 (0.43) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1000 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | claimed |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | KEMIRA OYJ (FI) | 2026-02-05 | — | — | US | claimed |
| EP-3707307-B1 | METHOD FOR MANUFACTURING A FIBROUS WEB | KEMIRA OYJ (FI) | 2025-07-23 | — | — | EP | claimed |
| WO-2025125110-A1 | GUANIDINE- AND CARBONATE-CONTAINING COMPOSITIONS | THOR GMBH (DE) | 2025-06-19 | — | — | WO | claimed |
| EP-4541876-A1 | LIQUID PRESERVATIVE-FREE DETERGENT COMPOSITION | Dalli-Werke GmbH & Co. KG (DE) | 2025-04-23 | — | — | EP | claimed |
| WO-2025032466-A1 | COATING COMPOSITION AND A PROCESS FOR ITS PREPARATION | KANSAI NEROLAC PAINTS LIMITED (IN) | 2025-02-13 | — | — | WO | claimed |
| US-20240293789-A1 | Encapsulation of Functional Additives in Partially-Open Microcapsules | SAS Nanotechnologies Inc. | 2024-09-05 | — | — | US | claimed |
| WO-2024175247-A1 | COSMETIC PRODUCTS AND CLEANING PRODUCTS STABILIZED AGAINST MICROBIAL ATTACK | THOR GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| WO-2024175245-A1 | SYNERGISTIC COMPOSITIONS CONTAINING GUANIDINE | THOR GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| WO-2024175248-A1 | COMPOSITIONS CONTAINING GUANIDINE AND 1,2-BENZISOTHIAZOLINE-3-ON | THOR GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| EP-1161150-A1 | THERAPEUTIC ANTIMICROBIAL COMPOSITIONS | ETHICON, INC. (US) | 2001-12-12 | — | — | EP | claimed |
| CN-1325848-A | Herbicidal 3-aryl-1,2,4-triazole derivative | BAYER AG (DE) | 2001-12-12 | — | — | CN | claimed |
| EP-1142554-A1 | Hair styling compositions | ROHM AND HAAS COMPANY (US) | 2001-10-10 | — | — | EP | claimed |
| US-6248343-B1 | MIXTURE OF TRICLOSAN AND PLANT EXTRACT | ETHICON, INC. | 2001-06-19 | — | — | US | claimed |
| WO-2001041573-A1 | THERAPEUTIC ANTIMICROBIAL COMPOSITIONS | ETHICON, INC. (US) | 2001-06-14 | — | — | WO | claimed |
| US-6022551-A | RAPIDLY DISINFECTS SURFACES INCLUDING THE HANDS; COMPRISING ALCOHOL, SPECIFIC ANTIMICROBIAL(S) SUCH AS BENZETHONIUM CHLORIDE, AND COCOPHOSPHATIDYL-DIMONIUM CHLORIDE, AND A COPOLYMER CARBOMER THICKENER | ETHICON, INC. (US) | 2000-02-08 | — | — | US | claimed |
| EP-0937394-A1 | Antimicrobial composition | ETHICON, INC. (US) | 1999-08-25 | — | — | EP | claimed |
| US-5939058-A | Hair styling compositions and method of enhancing the performance of hair fixative resins | ROHM AND HAAS COMPANY (US) | 1999-08-17 | — | — | US | claimed |
| CN-1175249-A | 3-aryl-1, 2, 4-triazole derivatives having herbicidal properties | BAYER AG (DE) | 1998-03-04 | — | — | CN | claimed |
| EP-0705595-A2 | Hair styling compositions | ROHM AND HAAS COMPANY (US) | 1996-04-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | CEL, TST, CD44 | CA12 73/4885CA1 52/4885CA9 357/4885 |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | POLL, UROD, RNGTT | CA12 2917/4885CA1 3423/4885CA9 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.